BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia

Oncogene. 2002 Dec 9;21(56):8547-59. doi: 10.1038/sj.onc.1206082.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Fusion Proteins, bcr-abl
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / metabolism*
  • Signal Transduction / drug effects

Substances

  • Antineoplastic Agents
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl